Junke Zhengyuan

Junke Zhengyuan (Beijing) Pharmaceutical Research Co., Ltd. (United-Power Pharma Tech Co., Ltd, UPP), as the only CRO in China fully certified by CNAS for bio-pharmaceutical analysis, provides bio-sample analysis for various large and small molecule drugs. It also has a complete bio-pharmaceutical process development and GMP pilot production base. The total operating area exceeds 12,000 square meters. It offers one-stop solutions for bio-pharmaceutical product development, production, analysis, and regulatory submission. The company is headquartered in Beijing, with branches in Shanghai, Tianjin, and Guangxi. The company has now developed into a team of more than 300 people, with a reasonable organizational structure, efficient modular operations, and stable and cohesive staff. Our scientists serve more than 200 clients worldwide. It is the largest regulatory analysis team for bio-pharmaceuticals in Asia. The company's core technical team was established in 2008 and has completed over 300 projects including pharmacokinetics, toxicokinetics, immunogenicity, and pharmacodynamics, covering peptides, monoclonal antibodies, bispecific antibodies, fusion proteins, nucleic acids, antibody-drug conjugates, and small molecule chemicals, spanning more than 70% of innovative bio-pharmaceutical varieties in China, accumulating rich project experience. All submitted projects have successfully passed NMPA inspections, and long-term cooperative relationships have been established with domestic and international clients.